SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 214 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $26,168,855 | -26.0% | 29,535,954 | +31.2% | 0.00% | 0.0% |
| Q3 2022 | $35,351,000 | -15.8% | 22,516,574 | +7.8% | 0.00% | 0.0% |
| Q2 2022 | $42,002,000 | +13.4% | 20,896,424 | +31.4% | 0.00% | 0.0% |
| Q1 2022 | $37,051,000 | -49.2% | 15,901,385 | +1.3% | 0.00% | -50.0% |
| Q4 2021 | $72,971,000 | -38.3% | 15,692,730 | +1.2% | 0.00% | -33.3% |
| Q3 2021 | $118,314,000 | -13.6% | 15,506,493 | +9.7% | 0.00% | 0.0% |
| Q2 2021 | $136,920,000 | +22.1% | 14,129,991 | +4.2% | 0.00% | 0.0% |
| Q1 2021 | $112,096,000 | +33.4% | 13,554,519 | +10.1% | 0.00% | +50.0% |
| Q4 2020 | $84,015,000 | -32.1% | 12,309,867 | +10.9% | 0.00% | -50.0% |
| Q3 2020 | $123,793,000 | +101.8% | 11,102,479 | +13.7% | 0.00% | +100.0% |
| Q2 2020 | $61,344,000 | +407.6% | 9,768,037 | +48.7% | 0.00% | +100.0% |
| Q1 2020 | $12,085,000 | -44.6% | 6,567,699 | +1.7% | 0.00% | 0.0% |
| Q4 2019 | $21,824,000 | +98.7% | 6,456,695 | +25.8% | 0.00% | – |
| Q3 2019 | $10,986,000 | -14.3% | 5,134,044 | +6.9% | 0.00% | – |
| Q2 2019 | $12,819,000 | -38.7% | 4,801,332 | +9.1% | 0.00% | -100.0% |
| Q1 2019 | $20,914,000 | +141.3% | 4,402,843 | +21.9% | 0.00% | – |
| Q4 2018 | $8,668,000 | -63.7% | 3,611,682 | -33.4% | 0.00% | -100.0% |
| Q3 2018 | $23,856,000 | -26.3% | 5,421,877 | +20.6% | 0.00% | 0.0% |
| Q2 2018 | $32,373,000 | +107.3% | 4,496,335 | +48.3% | 0.00% | 0.0% |
| Q1 2018 | $15,620,000 | +70.8% | 3,032,934 | +26.0% | 0.00% | – |
| Q4 2017 | $9,145,000 | +146.3% | 2,406,461 | +10.2% | 0.00% | – |
| Q3 2017 | $3,713,000 | -3.8% | 2,184,065 | +13.1% | 0.00% | – |
| Q2 2017 | $3,861,000 | -36.6% | 1,930,524 | +25.3% | 0.00% | – |
| Q1 2017 | $6,088,000 | -21.2% | 1,541,266 | -2.3% | 0.00% | – |
| Q4 2016 | $7,727,000 | -34.3% | 1,577,017 | +3.8% | 0.00% | -100.0% |
| Q3 2016 | $11,763,000 | +117.0% | 1,519,720 | +57.0% | 0.00% | – |
| Q2 2016 | $5,420,000 | -0.5% | 967,923 | -4.4% | 0.00% | – |
| Q1 2016 | $5,447,000 | -27.9% | 1,012,452 | +16.7% | 0.00% | -100.0% |
| Q4 2015 | $7,553,000 | +13.6% | 867,224 | +9.4% | 0.00% | – |
| Q3 2015 | $6,649,000 | -49.7% | 792,500 | +5.7% | 0.00% | -100.0% |
| Q2 2015 | $13,212,000 | +94.4% | 749,822 | +27.6% | 0.00% | – |
| Q1 2015 | $6,795,000 | +56.1% | 587,814 | +36.0% | 0.00% | – |
| Q4 2014 | $4,352,000 | +147.1% | 432,210 | +10.9% | 0.00% | – |
| Q3 2014 | $1,761,000 | -30.3% | 389,592 | +4.1% | 0.00% | – |
| Q2 2014 | $2,526,000 | +13.2% | 374,201 | +114.9% | 0.00% | – |
| Q1 2014 | $2,232,000 | +2407.9% | 174,135 | +1477.3% | 0.00% | – |
| Q4 2013 | $89,000 | – | 11,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |